logo
A Disabled Woman Wanted to Starve Herself to Death. The State Wouldn't Let Her. A New Doc Looks at Her Case (Exclusive)

A Disabled Woman Wanted to Starve Herself to Death. The State Wouldn't Let Her. A New Doc Looks at Her Case (Exclusive)

Yahoo19-07-2025
NEED TO KNOW
Director Reid Davenport's new documentary Life After examines the right-to-die question through the experiences of disabled people
Reid, who has cerebral palsy, uses the case of Elizabeth Bouvia, a young woman with cerebral palsy, as the centerpiece of the film
Bouvia was denied the right to starve herself in 1983Allowing a person with a dire health diagnosis or an unbearable level of pain to die might seem like an act of mercy to some people.
But what would happen if the government were to decide that anyone with a disability deserves the right to die? Filmmaker Reid Davenport confronts this question in his new documentary Life After, primarily through the story of Elizabeth Bouvia, a California woman with cerebral palsy who, at the age of 26, sought the legal right to starve herself to death.
This was in 1983, and some TV news broadcasts questioned why someone who was young and beautiful would want to end her life. She said she wanted to die because she hadn't been given the right to live in a society with a healthcare structure that valued the bottom line over her well-being.
Davenport, who also has cerebral palsy, and his producing partner at Multitude Films, Colleen Cassingham, kept hearing similar reasoning while making Life After, which is now playing in select theaters.
Bouvia articulated her argument well when her case moved to court — she was in pain, tired and bogged down by bureaucracy — but the state eventually sided with the hospital, which said it could not betray its oath to first do no harm. So what happened to this so-called pioneer in the right-to-die movement after the case ended?
That is the question Davenport set out to answer when he started working on Life After. Framed by Bouvia's story, the documentary explores expanded Canadian policies that allow nearly anyone with a disability to apply to die, why some disabled people have made the tough choice to die and how advocates for MAiD (medical aid in dying) defend the expansion of the policies from people with a terminal diagnosis to anyone with a disability.
The film amplifies varied voices and points of view, like Melissa Hickson, who says her husband Michael Hickson was denied lifesaving care because doctors decided his quality of life was too low, and Catherine Frazee, a professor who posits that you cannot address human suffering by killing people. One participant, Michal Kaliszan, details how he considered assisted dying after his mother, who was his primary caretaker, died, and he could no longer afford the care he needed.
While working on the documentary, Cassingham had to navigate a shift in taking right-to-die activism at face value as progressivism to fully understanding the implications of applying it to all disabled people.
"I thought assisted dying was really about personal choice and bodily autonomy, values that I'm deeply committed to," she tells PEOPLE. "And in learning from Reid and in working on this film, I realized there's so much more to the picture of how it actually works in society, and it's deeply linked with the ways that we do and don't value certain lives, and a deep-seated ableism that underpins so much of society."
Over the course of Life After, as Davenport searches for Bouvia's family and seeks to find out if she is still living, two themes emerge: that the focus on right-to-die policies ignores that so many disabled people are not given the right to live and that any one person deciding what a good quality of life is for someone else can be tricky.
"The themes at the heart of this film are not niche; they're not particular to the disability community. Things like healthcare, isolation and the way that we value other human lives are universal," Cassingham says. "Everyone has a stake in the fight for a society that is invested in care and in upholding each other's dignity in the systems that we build and live within."
Eventually, Davenport locates Bouvia's sisters, Teresa and Rebecca, and convinces them to appear on camera to talk about their sibling, who died in 2014. Encouraging the pair to open up about Bouvia was not easy, but Davenport's authenticity and transparency helped win them over.
"Their main concern was that Elizabeth's reputation and decisions were going to be questioned again, and we ensured that was not our intention," Davenport says. "Basically, trying to, with the audience, meet them where they were at, and not force them."
As Teresa and Rebecca share stories of Bouvia's life after the 1980s while the film visits people who have used or are considering using MAiD, it becomes clear that assisted dying may have its place in the medical system. However, as Davenport sees it, discussions about it should be handled carefully when the focus is on people with disabilities.
"We should be asking, 'How can we enable disabled people to live?' And support them, and allow them opportunities," he says. "There's this sinister perspective that we are a burden, that we suck up money. So there's this underlying incentive for the health industry to allow people to choose assisted suicide."
He continues, "What I would encourage people to do is to look at how we can better the lives of people with disabilities rather than leave them to die."
Near the end of the film, Davenport fills out the application for Canada's MAiD program to see how easy or hard it would be for him to qualify. What starts as a funny exercise becomes scary when he passes with flying colors. He reflects on this and on all the people he has met who have gone down the same path and says he can't imagine how different he would feel about his life without the support, care and passion he has.
In one particularly poignant moment, Cassingham agrees that her quality of life would also be greatly reduced without these things, but because she doesn't have a disability, she wouldn't be given the option to die because of it.
"Quality of life doesn't have much to do with the abilities of our bodies. When someone becomes disabled or is aging, there's a real grappling with what that means, because society has told us that what makes us productive and able to enjoy life revolves around our bodies and our ability to do certain things," she says. "But for me, I've experienced a real reframing of disability as a natural part of the fabric of human experience."
"I'm learning that quality of life resides somewhere else, and it involves the people around you, it involves being loved, and giving love and care," Cassingham adds. "And those are things we all have access to if we live in a society where care is fostered and relationships and interdependency is valued and fostered."
While Bouvia's life after her landmark court case quickly fell out of the news cycle, Davenport's film reappraises the right-to-die question — through the sweet recollections of Bouvia's sisters, home video footage and the context of many others who are choosing to die or questioning why it is even an option.
Life After is now playing in select theaters
Read the original article on People
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

"Never Has America Been More Vulnerable" — People Are Horrified After RFK Jr. Announced He's Cutting $500 Million In Funding For mRNA Vaccines
"Never Has America Been More Vulnerable" — People Are Horrified After RFK Jr. Announced He's Cutting $500 Million In Funding For mRNA Vaccines

Yahoo

time10 minutes ago

  • Yahoo

"Never Has America Been More Vulnerable" — People Are Horrified After RFK Jr. Announced He's Cutting $500 Million In Funding For mRNA Vaccines

I'm not sure if you've heard, but everyone's least favorite Health and Human Services Secretary, RFK Jr., recently announced that he's cancelling $500 million in funding for mRNA vaccine development. mRNA vaccines, which stand for messenger ribonucleic acid (RNA), are "highly effective" and "safe," according to the National Council on Aging, a nonprofit organization that works to improve the health of older adults in the US. According to the Cleveland Clinic, the mRNA vaccine helps teach your body to fight infectious diseases. More specifically, mRNA technology is utilized in the COVID-19 vaccine, which infectious disease experts say is what helped to slow the 2020 COVID-19 outbreak in the US. In a now-viral X video, RFK Jr. tried to explain the funding cuts saying, "HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses." Twitter: @SecKennedy According to CBS News, RFK Jr. reiterated that "HHS supports safe, effective vaccines for every American who wants them." Related: In response to the news, Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations, recently said, "I don't think I've seen a more dangerous decision in public health in my 50 years in the business." Following these vaccine funding cuts, millions have expressed deep concern for the future of medicine, as well as the impact of future pandemics in the US. Here's how medical professionals, lawmakers, and citizens are reacting: Commonly, people threw some personal digs at RFK Jr., with one person calling him a "despicable quack." ...and a pediatric MD calling him an "anti-vaxx weirdo." Related: While other medical professionals directly contradicted RFK Jr.'s claims about the mRNA vaccine, calling them "simply false." And called out RFK Jr.'s "fundamental misunderstanding of immunology." Another infectious disease doctor argued that RFK Jr.'s decision came from "ideology" and "online anti vax talking points." Related: And this medical professional and health writer called mRNA vaccines "one of the most important tools we have for preventing future pandemics." Another person expressed their anger about "throwing away" years of research: Even politicians have weighed in, with Senator Reverend Raphael Warnock calling the funding cuts a "tragedy." Related: "Whatever your reason for not voting or voting 3rd party, I promise it wasn't worth destroying our country over," this person wrote. And this person made a scary observation, writing: "A diseased population is easier to control..." And finally, this Reddit user summed up what many are feeling: "Imagine being so privileged to have lived in a tiny slice of human history when MILLIONS of people have been spared from pyrogens at the hands of vaccines……only to be somehow convinced the answer to the threat humanity faces going forward is to stop researching the most proven and effective medicine mankind has ever known." What are your thoughts? Let us know in the comments below. Also in In the News: Also in In the News: Also in In the News:

‘Going To Cost Lives': Former Surgeon General Shocked By RFK's Latest Move
‘Going To Cost Lives': Former Surgeon General Shocked By RFK's Latest Move

Yahoo

time10 minutes ago

  • Yahoo

‘Going To Cost Lives': Former Surgeon General Shocked By RFK's Latest Move

Robert F. Kennedy Jr.'s shock decision to cancel nearly half a billion dollars' worth of research projects because they're based on mRNA technology horrified vaccine experts Tuesday, among them President Donald Trump's own former surgeon general. Jerome Adams, who served as the nation's 20th surgeon general during Trump's first term, warned on social media that the decision will have very real negative consequences. 'I've tried to be objective & non-alarmist in response to current HHS actions – but quite frankly this move is going to cost lives,' he wrote. 'mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions.' Adams ended the missive with the 'head exploding' emoji. I've tried to be objective & non-alarmist in response to current HHS actions – but quite frankly this move is going to cost lives. mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions. 🤯 — Jerome Adams (@JeromeAdamsMD) August 6, 2025 In another thread, Adams blamed politicized messaging around vaccination during the coronavirus pandemic for leading to a widespread public misunderstanding of what vaccines actually accomplish. People believed that 'if you get this vaccine you won't get COVID,' said Adams, when the real aim was to prevent severe cases of the disease. Messenger RNA, or mRNA, technology has potential far beyond COVID. At Emory University, for instance, researchers are looking into using mRNA technology to train the immune system to cure cancer and chronic infections, thanks to a $24.8 million federal grant. The three-year program was funded by the Advanced Research Projects Agency for Health, or ARPA-H, which Kennedy merged with the Biomedical Advanced Research and Development Authority, or BARDA, in March — only to announce Tuesday he'd be pulling the funding for BARDA's mRNA investments. The inaugural director of ARPA-H, Dr. Renee Wegrzyn, was fired by the Trump administration in February amid mass layoffs at the Department of Health and Human Services and the Centers for Disease Control and Prevention. Tiba Biotech, another research company that saw its HHS contracts terminated Tuesday, is investigating using mRNA to combat tick-borne diseases. Thanks to climate change, more ticks are surviving through warmer winters, leading to a sharp increase in tick-borne illnesses. Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations, told The Associated Press the decision on mRNA research is a historically bad one. 'I don't think I've seen a more dangerous decision in public health in my 50 years in the business,' he said. Related... RFK Jr. Cancels $500 Million In Funding For Vaccine Development 800,000 Vaccine Doses The U.S. Pledged To Send To Africa Are About To Expire Instead RFK Jr.'s Stunning Claim About Black People And Vaccines Sparks Concern From Medical Experts RFK Jr. Keeps Telling A Flat-Out Lie About Childhood Vaccines — And Doctors Are Sick Of It

Walmart Employee's 'Magic' Side Hustle Surpasses $1 Million
Walmart Employee's 'Magic' Side Hustle Surpasses $1 Million

Entrepreneur

time11 minutes ago

  • Entrepreneur

Walmart Employee's 'Magic' Side Hustle Surpasses $1 Million

This Side Hustle Spotlight Q&A features 35-year-old New York City-based entrepreneur Mehek Khera. Khera is the founder and CEO of Niramaya Foods, a snack brand "rooted in wellness and inspired by Indian heritage." At the age of 24, Khera left New Delhi, India and immigrated to the U.S., where she landed a job at Walmart. Then burnout and health issues motivated her to start a health-forward side hustle. Niramaya is hitting $1 million in revenue for the first time in 2025. Learn how Khera transformed Niramaya into the successful business behind Naan pretzels and dips, here. Responses have been edited for length and clarity. Image Credit: Niramaya Foods. Mehek Khera. Want to read more stories like this? Subscribe to Money Makers, our free newsletter packed with creative side hustle ideas and successful strategies. Sign up here. What was your day job or primary occupation when you started your side hustle? I was working in retail at Walmart ecommerce, managing the category and supply chain for beauty and apparel. It was fast-paced, high-pressure and fulfilling in many ways — but over time, the long hours, lack of real food and stress began to take a toll on my body and mind. Related: This 26-Year-Old's Side Hustle Turned Full-Time Business Led to $100,000 in 2.5 Months and Is On Track for $2.5 Million in 2025 When did you start your side hustle, and where did you find the inspiration for it? Niramaya began to form in 2020, during a season of burnout and health struggles. I was dealing with chronic, undiagnosed autoimmune conditions and couldn't find answers. I left my job and turned to nutrition school — and through that, rediscovered the healing power of the foods I grew up with: vibrant dals, functional spices, sabzis made from fresh vegetables. I realized those recipes, passed down through generations, were medicine in themselves, and yet, I couldn't find them on any shelf in a way that felt clean, convenient or modern. That gap between culture and convenience, tradition and today, became the foundation for Niramaya. What were some of the first steps you took to get your side hustle off the ground? How much money/investment did it take to launch? I started in my kitchen, playing with recipes, taking feedback seriously and testing early versions at local markets. I knew I couldn't do this casually, so I saved up about $50,000 over two years to afford the minimum order quantities for our first co-manufacturer. I researched tirelessly, made hundreds of phone calls and eventually found a partner that aligned with our mission. We developed early packaging, launched a small website and put real products into people's hands. That's when the magic started. Related: This 29-Year-Old's Side Hustle Brought People 'to the Dark Green Side.' It Made $10,000 Within 2 Days and Sees 6 Figures a Month. Image Credit: Courtesy of Niramaya Foods Are there any free or paid resources that were especially helpful? Founder networks like Startup CPG, Naturally Network and SKU Accelerator made a world of difference. Slack groups for CPG founders were fast, brutally honest and incredibly supportive. On the tools side: Notion for tracking everything, Canva for design, QuickBooks for finances. But the most valuable resource by far? Talking to consumers face-to-face during demos. No software can replace that. If you could go back and change one process or approach, what would it be? I wouldn't change the path — every challenge taught me something I needed. But I would better prepare for the sheer resource drain. Budget twice the money and give yourself twice the time. Everything takes longer and costs more than you think — and that's not a flaw: It's just the nature of the game. Related: They Started a Side Hustle Producing an 'Obvious' Food Item. It Hit $300,000 Monthly Revenue Fast — On Track for Over $20 Million in 2025. What's something about this side hustle turned business that surprised or challenged you the most? How capital-intensive retail really is. Getting onto shelves is just the start — then comes the real work of driving velocity, educating the shopper and staying top-of-mind. Another challenge was re-educating people about Indian food. So many assume it's just "heavy curry." But our cuisine is so much more: vibrant, clean, gut-friendly, plant-forward. Translating that truth through packaging, product and language has been both a challenge and a privilege. Can you recall a specific moment when something went wrong — how did you handle it? At one of our early retail partners, our dips were priced too high and placed on the very top shelf — almost invisible to the consumer. Rather than panic, I calmly reached out to the buyer with sales data and shelf psychology insights and offered to support with demos and social posts if they would consider revisiting price and placement. They agreed. That moment reminded me that being proactive, respectful and solutions-oriented goes a long way in retail. Image Credit: Courtesy of Niramaya Foods How long did it take to see consistent revenue? We started seeing steady traction around nine months in. We began with smaller independents, a few regional stores and a lot of in-person events. It was grassroots, but it taught me how to listen, adapt and scale responsibly. What does growth and revenue look like today? Today, Niramaya is available in over 1,200 retail doors across the country, including Sprouts, Albertsons and a strong base of New York City independents. This will be our first year in seven figures. We're launching new SKUs and doubling down on retailers who believe in what we're building. What do you enjoy most about running this business? The deep creative satisfaction of building something that feels true and seeing it touch people. When someone says, "I've never tasted anything so clean and bold at once," I know we're doing something meaningful. We're not just selling food: We're shifting the perception of Indian flavors and bringing more people into the fold. Related: Tired of 'Culturally Obtuse' Products, This 27-Year-Old Took His Side Hustle From $1,000 a Month to 7-Figure Revenue: 'Pick the Right Opportunity to Pursue' What's your best piece of specific, actionable business advice? Start before you feel "ready." But don't build in a bubble. Get feedback constantly, especially from your customers. Stay lean. Build trust with your partners. Don't be afraid to ask dumb questions. And remember — relationships will carry you farther than any marketing campaign. Be generous, be honest and follow through. Ready to break through your revenue ceiling? Join us at Level Up, a conference for ambitious business leaders to unlock new growth opportunities.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store